During the past decade, Brest Regional Oncology Dispensary conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Brest Regional Oncology Dispensary" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Helsinn Healthcare SA" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Samsung Bioepis Co., Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brest Regional Oncology Dispensary" #1 collaborator was "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Brest Regional Oncology Dispensary" are "Breast Cancer" (1 trials), "Drug and/or Toxin-induced Diarrhea" (1 trials), "Follicular Lymphoma" (1 trials), "Lung Cancer" (1 trials) and "Metastatic Castrate Sensitive Prostate Cancer" (1 trials). Many other conditions were trialed in "Brest Regional Oncology Dispensary" in a lesser frequency.

Most popular intervention types in "Brest Regional Oncology Dispensary" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "Abiraterone acetate (AA)" (1 trials), "Bevacizumab" (1 trials) and "Cetrelimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brest Regional Oncology Dispensary" are 5 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Brest Regional Oncology Dispensary". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Brest Regional Oncology Dispensary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Brest Regional Oncology Dispensary, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".